Is it time to bite the dosimetry bullet in patients receiving Lu-177-octreotate PRRT for the management of symptomatic neuroendocrine tumours?
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING（2014）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要